MedTrace Logo

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

NCT03560102 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-10-22

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the efficacy of a dedicated Magnetic Resonance guided High Intensity Focused Ultrasound (MR-HIFU) unit in ablating breast cancer by comparing MR imaging and pathologic specimen after resection.

Single-center, single-arm, non-randomized trial

Conditions

  • Breast Cancer, Invasive Ductal

Interventions

DEVICE

Philips Sonalleve® MR-HIFU Breast Therapy System

The breast tumor lesion of qualified study patients will be treated with MR-HIFU under procedural sedation with Propofol and Ketamine.

Sponsors & Collaborators

  • Kantonsspital Winterthur KSW

    lead OTHER

Principal Investigators

  • Christoph A Binkert, MD · Kantonsspital Winterthur KSW

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2020-02-05
Completion
2020-02-05

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03560102 on ClinicalTrials.gov